VOHRINGER; Verena
Patent Applications and Registrations
Patent applications and USPTO patent grants for VOHRINGER; Verena.The latest application filed is for "disubstituted benzothienyl-pyrrolotriazines and their use as fgfr kinase inhibitors".
- VOHRINGER; Verena - Wolfegg DE
- Vohringer; Verena - Wuppertal DE
| Patent | Date |
|---|---|
| Disubstituted Benzothienyl-pyrrolotriazines And Their Use As Fgfr Kinase Inhibitors App 20220153745 - BROHM; Dirk ; et al. | 2022-05-19 |
| Disubstituted Benzothienyl-pyrrolotriazines And Their Use As Fgfr Kinase Inhibitors App 20190016724 - BROHM; Dirk ; et al. | 2019-01-17 |
| Substituted benzothienyl-pyrrolotriazines and uses thereof in the treatment cancer Grant 9,598,416 - Collin , et al. March 21, 2 | 2017-03-21 |
| Hydroxymethylaryl-substituted pyrrolotriazines as ALK1 inhibitors Grant 9,040,691 - Klar , et al. May 26, 2 | 2015-05-26 |
| Substituted Benzothienyl - Pyrrolotriazines And Uses Thereof In The Treatment Cancer App 20150080371 - Collin; Marie-Pierre ; et al. | 2015-03-19 |
| Substituted Benzothienyl-pyrrolotriazines And Uses Thereof App 20150031676 - Lobell; Mario ; et al. | 2015-01-29 |
| Disubstituted Benzothienyl-pyrrolotriazines And Their Use As Fgfr Kinase Inhibitors App 20140336173 - Brohm; Dirk ; et al. | 2014-11-13 |
| Hydroxymethylaryl-substituted Pyrrolotriazines As Alk1 Inhibitors App 20140256718 - Klar; Jurgen ; et al. | 2014-09-11 |
| Sulphoximine-substituted quinoline and quinazoline derivatives as kinase inhibitors Grant 8,003,787 - Eis , et al. August 23, 2 | 2011-08-23 |
| Novel Sulphoximine-substituted Quinoline And Quinazoline Derivatives As Kinase Inhibitors App 20090226377 - EIS; Knut ; et al. | 2009-09-10 |
| Benzofuran derivatives Grant 7,015,246 - Schmeck , et al. March 21, 2 | 2006-03-21 |
| Tetrahydroisoquinoline derivatives App 20050234096 - Bischoff, Hilmar ; et al. | 2005-10-20 |
| Indole derivatives App 20050032874 - Haning, Helmut ; et al. | 2005-02-10 |
| Benzofuran derivatives App 20040220415 - Schmeck, Carsten ; et al. | 2004-11-04 |
| Diphenylmethane derivatives Grant 6,803,480 - Haning , et al. October 12, 2 | 2004-10-12 |
| Indole derivatives Grant 6,794,406 - Haning , et al. September 21, 2 | 2004-09-21 |
| Diphenyl derivatives Grant 6,777,442 - Haning , et al. August 17, 2 | 2004-08-17 |
| Arylsulphonamides and analogues Grant 6,727,279 - Mittendorf , et al. April 27, 2 | 2004-04-27 |
| Indazoles Grant 6,608,049 - Woltering , et al. August 19, 2 | 2003-08-19 |
| Diphenyl derivatives App 20030105078 - Haning, Helmut ; et al. | 2003-06-05 |
| Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases Grant 6,573,278 - Mittendorf , et al. June 3, 2 | 2003-06-03 |
| Indole derivatives App 20030078288 - Haning, Helmut ; et al. | 2003-04-24 |
| Novel arylsulphonamides and analogues App 20030073727 - Mittendorf, Joachim ; et al. | 2003-04-17 |
| Aryl sulphonamide amino acid esters and analogues Grant 6,545,050 - Mittendorf , et al. April 8, 2 | 2003-04-08 |
| Amino-and amido-diphenyl ethers App 20030027862 - Haning, Helmut ; et al. | 2003-02-06 |
| Indazoles App 20020193610 - Woltering, Michael ; et al. | 2002-12-19 |
| Aryl sulphonamides and analogues Grant 6,469,054 - Mittendorf , et al. October 22, 2 | 2002-10-22 |
| Arylsulfonamides and analogues App 20020072529 - Mittendorf, Joachim ; et al. | 2002-06-13 |
| Use of known agonists of the central cannabinoid receptor CB1 App 20010034344 - Mittendorf, Joachim ; et al. | 2001-10-25 |
| Use of known agonists of the central cannabinoid receptor CB1 Grant 6,284,788 - Mittendorf , et al. September 4, 2 | 2001-09-04 |
| Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases Grant 6,262,112 - Mittendorf , et al. July 17, 2 | 2001-07-17 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 